Patent Acquisition Opportunity
GTT Group is delighted to exclusively represent the acquisition of Solaana MD, a physician-founded, patent-protected dermocosmetics brand. Solaana MD has developed and commercialized a first-in-class, high-absorption, topical Vitamin D delivery system that addresses a well-documented, unmet need for millions of consumers with sensitive skin conditions or vitamin D deficiency.
The acquisition includes the full brand, and patented compound, a turnkey supply chain, existing sales, and committed founder transition support.
TECHNOLOGY AREA(S): Dermocosmetics, Vitamin D
EOU: GTT Group Analysts are available to review EOU at interested parties’ convenience to support due diligence.
RELEVANT MARKET(S): Dermacosmetic, Skincare, Topical Nutraceuticals
JURISDICTION(S): US
Please reach out to Tyler Mckinley (tmckinley@gttgrp.com) for additional information regarding this acquisition opportunity.
Are you interested in this portfolio? Fill out the contact form below. Our team will follow up with an in-depth opportunity summary. You may also reach out to Tyler McKinley directly at (503) 351-8945 or tmckinley@gttgrp.com.